Orthopedic Implants in Delaware
2 vendors serving Delaware
Find orthopedic implants vendors in Delaware. MedIndexer lists vendors headquartered in Delaware alongside nationwide vendors that serve Delaware. Compare profiles, review service areas, and contact vendors directly — no middleman, no fees for buyers.
Top orthopedic implants in Delaware
Meticuly Co., Ltd.
Meticuly is a global 3D printing medical device manufacturer specializing in patient-specific implants for craniofacial and orthognathic surgery. The company provides an end-to-end solution integrating AI-powered implant design, CT scan analysis, titanium implant engineering, and additive manufacturing. Core product lines include cranio-maxillofacial implants for cranioplasty, orbital reconstruction, mid-face reconstruction, and mandibular reconstruction, as well as patient-specific implants (PSI) for orthognathic and minimally invasive surgical procedures. Meticuly serves over 240 hospitals worldwide and has supported more than 2,500 patients through collaboration with over 850 surgeons. The company combines advanced algorithms with high-precision 3D printing to deliver customized, ready-to-use bone implants tailored to individual patient anatomy. Services span from initial imaging through design, manufacturing, and surgical delivery. No specific FDA or ISO certifications were identified in the provided content.
ZuriMED Technologies AG
ZuriMED Technologies AG is a Swiss medical device manufacturer specializing in orthopedic soft tissue repair innovations. The company develops and commercializes the FiberLocker® System, a mechanical rotator cuff augmentation device designed to address the clinical challenge of high postoperative retear rates (24–94%) following rotator cuff repair. The FiberLocker® System provides immediate structural integrity to repaired and injured tendons by mechanically augmenting the repair site, reducing the risk of suture-tendon interface failure ('cheesewiring'). The device has received FDA 510(k) clearance as of February 2025. ZuriMED is based in Zurich and has demonstrated strong institutional partnerships with the University of Zurich, ETH Zurich, and the Balgrist University Hospital, reflecting its commitment to evidence-based product development. The company has secured significant funding, including a Series-A round of 14.5 million CHF (August 2023), and has received recognition through multiple Swiss innovation awards and grants from Innosuisse. ZuriMED actively participates in major orthopedic conferences including Shoulder 360, AANA, and AOSSM, positioning itself as a key player in the orthopedic surgical device market. The organization serves the North American and European markets and continues to expand its international presence.